Nicole Thibodeau, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3726 Savanna Palms Ct, Lakewood Ranch, FL 34211 Phone: 941-444-9515 |
Mrs. Ana Smith, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15652 Lemon Fish Dr, Lakewood Ranch, FL 34202 Phone: 941-320-7054 |
Jennifer Michelle Chivas, RN, BSN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 7345 International Pl Ste 109, Lakewood Ranch, FL 34240 Phone: 941-254-2502 |
Kristina Lisa Lipe, RN FA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 6310 Heacth Parkway Suite 110, Lakewood Ranch, FL 34202 Phone: 941-907-8174 Fax: 941-907-8177 |
News Archive
The adult human circulatory system contains between 20 and 30 trillion red blood cells (RBCs), the precise size and number of which can vary from person to person. Some people may have fewer, but larger RBCs, while others may have a larger number of smaller RBCs. Although these differences in size and number may seem inconsequential, they raise an important question: Just what controls these characteristics of RBCs?
In an invited perspective published January 6, 2017, in Science, Hamilton Farris, PhD, Associate Professor-Research at LSU Health New Orleans Neuroscience Center of Excellence, finds that the key insight of an important study by Nachev, et al. is that perception can drive the evolution of observable traits.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.
ReWalk Robotics Ltd., the leading global exoskeleton manufacturer, unveiled today the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking the company's sixth generation community use product. The ReWalk Personal 6.0 offers those in the spinal cord injured community the most functional exoskeleton system with the fastest walking speed and the most precise fit, among many other key benefits.
› Verified 7 days ago